Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24-Reference-Cited by-同舟云学术

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

Published:2013-04-20 Issue:5 Volume:73 Page:831-837
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Saadoun David,Resche Rigon M,Thibault V,Longuet M,Pol S,Blanc F,Pialoux G,Karras A,Bazin-Karra D,Cazorla C,Vittecoq D,Musset L,Decaux O,Ziza J M,Lambotte O,Cacoub Patrice

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference24 articles.

1. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients;Gorevic;Am J Med,1980

2. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia;Saadoun;Arch Intern Med,2006

3. Cryoglobulinemia—a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity;Meltzer;Am J Med,1966

4. A role for hepatitis C virus infection in type II cryoglobulinemia;Agnello;N Engl J Med,1992

5. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis;Saadoun;N Engl J Med,2011

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative study of different antiviral treatment protocols in HCV related cryoglobulinemic vasculitis;Scientific Reports;2024-05-23

2. Chronic Hepatitis C;Clinical Cases in Hepatology;2021-10-26

3. Remission of long-term hepatic and renal disease induced by HCV after direct-acting antivirals therapy;Brazilian Journal of Nephrology;2021-03

4. Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review;Advances in Experimental Medicine and Biology;2020

5. Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients;Annals of Hepatology;2019-09